Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
20%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
WHCA.L
134
HOLDINGS
22%
ALSO IN XSDR.DE
XSDR.DE
28
HOLDINGS
96%
ALSO IN WHCA.L
SECTOR DRIFT (WHCA.L minus XSDR.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WHCA.L |
Weight in XSDR.DE |
Overlap | |
|---|---|---|---|---|
| NOVARTIS AG | 5.5% | 18.3% | 5.5% | |
| ASTRAZENECA PLC | 3.4% | 18.0% | 3.4% | |
| NOVO NORDISK A/S-B | 1.9% | 10.0% | 1.9% | |
| ALCON, INC. | 1.3% | 2.1% | 1.3% | |
| ESSILOR INTERNATIONAL | 0.9% | 4.1% | 0.9% | |
WHCA.L Overweight Relative to XSDR.DE
| ELI LILLY & CO | 10.3% | |
| JOHNSON & JOHNSON | 5.4% | |
| ABBVIE INC | 4.9% | |
| UNITEDHEALTH GROUP INC | 4.0% | |
| MERCK & CO. INC. | 3.4% | |
| GILEAD SCIENCES INC | 2.9% | |
| AMGEN INC | 2.0% | |
| VERTEX PHARMACEUTICALS INC | 1.9% | |
| ELEVANCE HEALTH INC | 1.9% | |
| MCKESSON CORP | 1.8% |
WHCA.L Underweight Relative to XSDR.DE
| NOVARTIS AG-REG | -18.3% | |
| ASTRAZENECA PLC | -14.6% | |
| NOVARTIS AG | -12.8% | |
| NOVO NORDISK A/S-B | -8.1% | |
| SANOFI-AVENTIS | -5.5% | |
| ESSILOR INTERNATIONAL | -3.2% | |
| LONZA GROUP AG-REG | -2.7% | |
| ARGEN-X SE | -2.7% | |
| HALEON PLC | -2.1% | |
| UCB SA | -1.6% |